Temporal profile of the vascular anatomy evaluated by 9.4-T magnetic resonance angiography and histopathological analysis in mice lacking RNF213: a susceptibility gene for moyamoya disease
- PMID: 24440776
- DOI: 10.1016/j.brainres.2014.01.011
Temporal profile of the vascular anatomy evaluated by 9.4-T magnetic resonance angiography and histopathological analysis in mice lacking RNF213: a susceptibility gene for moyamoya disease
Abstract
Moyamoya disease (MMD) is a chronic occlusive cerebrovascular disease with unknown etiology. Recent genome-wide and locus-specific association studies identified RNF213 as an important MMD susceptibility gene. However, the exact mechanism by which an abnormality in RNF213 leads to MMD is unknown. To evaluate the role of RNF213 in the etiology of MMD, we generated RNF213-deficient mice (RNF213-/-) by deleting exon 32 of RNF213 by the Cre-lox system, and investigated whether they developed MMD. The temporal profile of cervical/intracranial arteries was evaluated by 9.4-T magnetic resonance angiography (MRA). The anatomy of the circle of Willis was analyzed by a trans-cardiac injection of carbon black dye. The common carotid arteries (CCA) were sectioned and the arterial wall thickness/thinness was evaluated by Elastica-Masson staining before and after CCA ligation, which selectively induced vascular hyperplasia. As a result, RNF213-/- grew normally, and no significant difference was observed in MRA findings, the anatomy of the circle of Willis, or vascular wall thickness/thinness between RNF-/- and wild-type littermates (Wt.) under normal conditions until 64 weeks of age. However, Elastica-Masson staining demonstrated that both the intima and medial layer were significantly thinner after CCA ligation in RNF213-/- than in Wt. after 14 days (P<0.01). In conclusion, mice lacking the RNF213 gene did not spontaneously develop MMD, indicating that a functional loss of RNF213 did not sufficiently induce MMD. Suppression of vascular remodeling in RNF213-/- requires further examination to clarify the role of RNF213.
Keywords: Homologous recombination; Knockout mice; Moyamoya disease; RNF213.
Copyright © 2014 Elsevier B.V. All rights reserved.
Similar articles
-
Temporal profile of the vascular anatomy evaluated by 9.4-tesla magnetic resonance angiography and histological analysis in mice with the R4859K mutation of RNF213, the susceptibility gene for moyamoya disease.Brain Res. 2015 Oct 22;1624:497-505. doi: 10.1016/j.brainres.2015.07.039. Epub 2015 Aug 24. Brain Res. 2015. PMID: 26315378
-
Temporal profile of magnetic resonance angiography and decreased ratio of regulatory T cells after immunological adjuvant administration to mice lacking RNF213, a susceptibility gene for moyamoya disease.Brain Res. 2016 Jul 1;1642:1-9. doi: 10.1016/j.brainres.2016.03.009. Epub 2016 Mar 10. Brain Res. 2016. PMID: 26972532
-
Increased vascular MMP-9 in mice lacking RNF213: moyamoya disease susceptibility gene.Neuroreport. 2014 Dec 17;25(18):1442-6. doi: 10.1097/WNR.0000000000000289. Neuroreport. 2014. PMID: 25383461
-
Rare variants of RNF213 and moyamoya/non-moyamoya intracranial artery stenosis/occlusion disease risk: a meta-analysis and systematic review.Environ Health Prev Med. 2017 Nov 2;22(1):75. doi: 10.1186/s12199-017-0680-1. Environ Health Prev Med. 2017. PMID: 29165161 Free PMC article. Review.
-
A new horizon of moyamoya disease and associated health risks explored through RNF213.Environ Health Prev Med. 2016 Mar;21(2):55-70. doi: 10.1007/s12199-015-0498-7. Epub 2015 Dec 10. Environ Health Prev Med. 2016. PMID: 26662949 Free PMC article. Review.
Cited by
-
Angiogenic and inflammatory responses in human induced microglia-like (iMG) cells from patients with Moyamoya disease.Sci Rep. 2023 Sep 8;13(1):14842. doi: 10.1038/s41598-023-41456-z. Sci Rep. 2023. PMID: 37684266 Free PMC article.
-
Rnf-213 Knockout Induces Pericyte Reduction and Blood-Brain Barrier Impairment in Mouse.Mol Neurobiol. 2023 Nov;60(11):6188-6200. doi: 10.1007/s12035-023-03480-y. Epub 2023 Jul 12. Mol Neurobiol. 2023. PMID: 37438553
-
Plasma exosomal microRNAs are non-invasive biomarkers of moyamoya disease: A pilot study.Clinics (Sao Paulo). 2023 Jul 4;78:100247. doi: 10.1016/j.clinsp.2023.100247. eCollection 2023. Clinics (Sao Paulo). 2023. PMID: 37413774 Free PMC article.
-
RNF213 loss-of-function promotes pathological angiogenesis in moyamoya disease via the Hippo pathway.Brain. 2023 Nov 2;146(11):4674-4689. doi: 10.1093/brain/awad225. Brain. 2023. PMID: 37399508 Free PMC article.
-
Moyamoya Disease and Flow Velocity.JMA J. 2023 Jan 16;6(1):25-26. doi: 10.31662/jmaj.2022-0191. Epub 2022 Dec 26. JMA J. 2023. PMID: 36793529 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
